HomeComparePXH vs ARCC

PXH vs ARCC: Dividend Comparison 2026

PXH yields 3.79% · ARCC yields 10.65%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PXH wins by $1.1K in total portfolio value· pulled ahead in Year 5
10 years
PXH
PXH
● Live price
3.79%
Share price
$26.73
Annual div
$1.01
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.6K
Annual income
$483.34
Full PXH calculator →
ARCC
Ares Capital Corporation
● Live price
10.65%
Share price
$18.02
Annual div
$1.92
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$1.14
Full ARCC calculator →

Portfolio growth — PXH vs ARCC

📍 PXH pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPXHARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PXH + ARCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PXH pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PXH
Annual income on $10K today (after 15% tax)
$322.06/yr
After 10yr DRIP, annual income (after tax)
$410.84/yr
ARCC
Annual income on $10K today (after 15% tax)
$905.66/yr
After 10yr DRIP, annual income (after tax)
$0.97/yr
At 15% tax rate, PXH beats the other by $409.87/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PXH + ARCC for your $10,000?

PXH: 50%ARCC: 50%
100% ARCC50/50100% PXH
Portfolio after 10yr
$25.0K
Annual income
$242.24/yr
Blended yield
0.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

PXH
No analyst data
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+21.4% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PXH buys
0
ARCC buys
0
No recent congressional trades found for PXH or ARCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPXHARCC
Forward yield3.79%10.65%
Annual dividend / share$1.01$1.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$25.6K$24.5K
Annual income after 10y$483.34$1.14
Total dividends collected$4.3K$1.1K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: PXH vs ARCC ($10,000, DRIP)

YearPXH PortfolioPXH Income/yrARCC PortfolioARCC Income/yrGap
1$11,079$378.90$11,373$532.74$294.00ARCC
2$12,247$392.32$12,608$279.46$361.00ARCC
3$13,509$405.30$13,809$142.90$300.00ARCC
4$14,873$417.84$15,042$72.20$169.00ARCC
5← crossover$16,344$429.91$16,341$36.27+$3.00PXH
6$17,929$441.53$17,732$18.18+$197.00PXH
7$19,637$452.68$19,231$9.10+$406.00PXH
8$21,475$463.36$20,851$4.55+$624.00PXH
9$23,452$473.58$22,605$2.28+$847.00PXH
10$25,577$483.34$24,504$1.14+$1.1KPXH

PXH vs ARCC: Complete Analysis 2026

PXHStock

The Invesco RAFI Emerging Markets ETF (Fund) is based on the RAFI Fundamental Select Emerging Markets 350 Index (Index). The Fund will generally invest at least 90% of its total assets in the securities that comprise the Index as well as American Depository Receipts (ADRs) and global depositary receipts (GDRs) that represent securities in the Index. The Index is designed to track the performance of the largest emerging market equities, selected based on the following four fundamental measures of firm size: book value, cash flow, sales and dividends. The equities with the highest fundamental strength are weighted according to their fundamental scores. The Index is computed using the net return, which withholds applicable taxes for non-resident investors. The Fund and the Index are reconstituted annually.Effective close of business March 21, 2025, FTSE RAFI Emerging Index ("Current Underlying Index") will change to the RAFI Fundamental Select Emerging Markets 350 Index ("New Underlying Index"). The New Underlying Index will replace the Fund’s Current Underlying Index. The Fund’s name will change to “Invesco RAFI Emerging Markets ETF”. Additionally, the Fund's management fee will reduce to 47 bps. As of 08/31/2025 the Fund had an overall rating of 4 stars out of 696 funds and was rated 4 stars out of 696 funds, 4 stars out of 620 funds and 4 stars out of 448 funds for the 3-, 5- and 10- year periods, respectively. Source: Morningstar Inc. Ratings are based on a risk-adjusted return measure that accounts for variation in a fund's monthly performance, placing more emphasis on downward variations and rewarding consistent performance. Open-end mutual funds and exchange-traded funds are considered a single population for comparison purposes. Ratings are calculated for funds with at least a three year history. The overall rating is derived from a weighted average of three-, five- and 10-year rating metrics, as applicable, excluding sales charges and including fees and expenses. ©2025 Morningstar Inc. All rights reserved. The information contained herein is proprietary to Morningstar and/or its content providers. It may not be copied or distributed and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance does not guarantee future results. The top 10% of funds in a category receive five stars, the next 22.5% four stars, the next 35% three stars, the next 22.5% two stars and the bottom 10% one star. Ratings are subject to change monthly. Had fees not been waived and/or expenses reimbursed currently or in the past, the Morningstar rating would have been lower. Ratings for other share classes may differ due to different performance characteristics.

Full PXH Calculator →

ARCCBDC

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Full ARCC Calculator →
📬

Get this PXH vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PXH vs SCHDPXH vs JEPIPXH vs OPXH vs KOPXH vs MAINPXH vs HTGCPXH vs GBDCPXH vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.